ALB
Albemarle Corporation
NYSE · Basic Materials · Chemicals - Specialty · US
$126.96
−3.93%Year over year
Reported trailing growth
- Revenue
- +18.3%
- EBITDA
- +113.3%
- EBIT
- +413.9%
- EPS
- +105.1%
- Free cash flow
- +787.9%
- Operating cash flow
- +135.0%
Forward estimates
Based on analyst estimates
- Revenue
- +2.6%
- EBITDA
- +146.6%
- EPS
- +1960.2%
Three-year CAGR
- Revenue
- -11.1%
- EBITDA
- -46.4%
- EBIT
- -66.5%
- Net income
- +56.7%
- EPS
- +48.7%
- Free cash flow
- +2.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026